Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SMP-3124 |
Synonyms | |
Therapy Description |
SMP-3124 is a liposome-encapsulated Chk1 inhibitor, which potentially induces antitumor activity (Cancer Res (2024) 84 (6_Supplement): 5724). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SMP-3124 | SMP3124|SMP 3124|SMP-3124LP | CHK1 Inhibitor 18 | SMP-3124 is a liposome-encapsulated Chk1 inhibitor, which potentially induces antitumor activity (Cancer Res (2024) 84 (6_Supplement): 5724). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06526819 | Phase Ib/II | SMP-3124 | A Phase 1/2 Study of SMP-3124LP in Adults With Advanced Solid Tumors | Recruiting | USA | 1 |